Medical Lab Equipment Appraisal

Medical lab equipment includes regulated instruments used in clinical diagnostics, research, and laboratory testing. This encompasses FDA-cleared devices, ISO-calibrated analytical instruments, diagnostic systems, and supporting infrastructure. Equipment ranges from handheld diagnostic devices to room-sized analytical systems, including mass spectrometers, chromatographs, imaging equipment, and specialized research instrumentation.

Valuation uses three approaches: the Cost Approach (replacement cost minus depreciation), the Market Approach (comparable sales and auction data), and the Income Approach (income-generation potential for revenue-producing equipment). USPAP-compliant appraisers select the most appropriate method based on equipment type, condition, and the intended use of the valuation.

Both. We value single high-value instruments as well as complete laboratory portfolios spanning hundreds of assets across multiple departments. For large inventories we organize the report by department or asset class so every value conclusion is easy to trace and support.

Essential documentation includes equipment specifications, purchase invoices, maintenance records, calibration certificates, and current condition reports. For high-value systems, we also request service history, software licensing information, and any upgrade documentation. Photos and videos of equipment operation help verify functionality and condition.

Single instruments and smaller portfolios are often completed within a week; specialized research systems and large hospital inventories typically take two to three weeks. We confirm the timeline up front. Rush services are available for time-sensitive financing transactions and insurance claim requirements.

Our reports are prepared in accordance with USPAP and structured to meet the requirements lenders apply to equipment financing and SBA loans, along with the documentation insurers request for coverage and claims. Each report includes the methodology, market data, and value conclusions institutional reviewers expect, though the lender or insurer always makes the final determination.